Cargando…
EXPERIMENTAL STUDY OF CHEMOTHERAPY RELATED LEUKOCYTOPENIA TREATED BY VARIOUS PEROAL LEUCOCYTE INCREASING DRUGS
BACKGROUND: Clinically, the patients with significant WBC decrease are mostly administered G-CSF, this kind of drugs is expensive and adverse reactions are often seen. In contrast, oral leucocyte increasing drug has small adverse reactions, can be used for longer time and can improve the continuity...
Autores principales: | Xiping, Zhang, Hongjian, Yang, Dehong, Zou, Xiangming, He, Xingfei, Yu, Yongfeng, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
African Traditional Herbal Medicine Supporters Initiative (ATHMSI)
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5411866/ https://www.ncbi.nlm.nih.gov/pubmed/28480393 http://dx.doi.org/10.21010/ajtcam.v14i1.17 |
Ejemplares similares
-
Cellulitis with Leukocytopenia as an Initial Sign of Acute Promyelocytic Leukemia
por: Sakamoto, Sachiko, et al.
Publicado: (2012) -
Transient leukocytopenia following combination therapy for COVID-19
por: Tsuchiya, Kazuo, et al.
Publicado: (2022) -
Prognosis and endocrine therapy selection for patients with low hormone receptor-positive breast cancer following neoadjuvant chemotherapy: A retrospective study of 570 patients in China
por: Ding, Yuqin, et al.
Publicado: (2019) -
Impact on survival of estrogen receptor, progesterone receptor and Ki-67 expression discordance pre- and post-neoadjuvant chemotherapy in breast cancer
por: Ding, Yuqin, et al.
Publicado: (2020) -
The Evolutionary History and Spatiotemporal Dynamics of the Fever, Thrombocytopenia and Leukocytopenia Syndrome Virus (FTLSV) in China
por: Huang, Xueyong, et al.
Publicado: (2014)